Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.
Explore how type 2 inflammation drives the production of eosinophils in severe asthma.
Explore how type 2 inflammation drives the production of FeNO in severe asthma

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr. Brian Kim explores the histaminergic and nonhistaminergic mechanisms of itch, highlighting how type 2 cytokines like IL-4 serve as central orchestrators of neuronal sensitization and immune–nervous system cross-talk.

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr. Brian Kim describes the dynamic neuroimmune interactions in chronic pruritic skin diseases, emphasizing how type 2 cytokines and sensory nerves actively influence both itch perception and tissue inflammation.

Understand the drivers of lung function decline in chronic obstructive pulmonary disease (COPD), including chronic inflammation, key risk factors, and the impact on patient well-being .
See how type 2 inflammation underlies remodeling processes in asthma.
An infographic to explore the the key roles of CCL17 (TARC) in atopic dermatitis.

Join Dr. Hanania to understand how to identify patients at risk of fixed airway obstruction in clinical settings.

Dr. Stephanie Christenson discusses the association between COPD exacerbations and the increased risks of morbidity and mortality

Dr. Mario Castro discusses how COPD exacerbations can predict future exacerbations and lead to progressive lung function loss in COPD patients.